Skip to content
OpenCapital
Get started

Abbott ABT Established Pharmaceuticals — Total Assets

Other segment segments

Medical Devices
$10.98B+9.5%
Diagnostic Products
$9.63B+22.8%
Nutritional Products
$4.9B+5.8%

Similar metrics at other companies

Opko Health logo
OPKPharmaceutical — Total Assets
$1.28B-5.0%
AptarGroup logo
ATRPharma — Total Assets
$2.28B+11.0%
Cardinal Health logo
CAHPharmaceutical and Specialty Solutions — Total Assets
$41.03B+14.8%
VAN
VANIBiopharm Division — Total Assets
$41.9M+20.7%
The Oncology Institute, Inc. logo
TOISpecialty pharmacy — Total Assets
$29.14M—
Johnson & Johnson logo
JNJInnovative Medicine — Total Assets
$78.86B+4.5%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$179.51B-18.3%
Enterprise value$206.76B-13.1%
P/E33.1×+17.4×
P/S3.9×-1.2×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's established pharmaceuticals — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's established pharmaceuticals — total assets?
Abbott (ABT) reported established pharmaceuticals — total assets of $3.67B in Q1 2026.
How has Abbott's established pharmaceuticals — total assets changed year-over-year?
Abbott's established pharmaceuticals — total assets increased by 6.3% year-over-year, from $3.45B to $3.67B.
What does established pharmaceuticals — total assets mean?
This metric represents the aggregate value of all resources, including inventory, accounts receivable, property, and intangible assets, that are specifically allocated to the Established Pharmaceuticals segment. It serves as a measure of the capital base required to support the segment's revenue generation and market presence. Investors use this to evaluate the asset intensity and capital efficiency of the segment's operations.